Basal expression of RAD51 foci predicts olaparib response in patient-derived ovarian cancer xenografts (vol 126, pg 122, 2022 )

被引：1
|
作者：
Guffanti, F.
Alvisi, M. F.
Anastasia, A.
Ricci, F.
Chiappa, M.
Llop-Guevara, A.
Serra, V.
Fruscio, R.
Degasperi, A.
Nik-Zainal, S.
Bani, M. R.
Lupia, M.
Giavazzi, R.
Rulli, E.
Damia, G.
机构：
[1] Istituto di Ricerche Farmacologiche Mario Negri IRCCS,Laboratory of Molecular Pharmacology, Department of Oncology
[2] Istituto di Ricerche Farmacologiche Mario Negri IRCCS,Laboratory of Methodology for Clinical Research, Department of Oncology
[3] Istituto di Ricerche Farmacologiche Mario Negri IRCCS,Laboratory of Cancer Metastasis Therapeutics, Department of Oncology
[4] Vall d’Hebron Institute of Oncology,Experimental Therapeutics Group
[5] University of Milan Bicocca,Clinic of Obstetrics and Gynecology, Department of Medicine and Surgery, San Gerardo Hospital
[6] University of Cambridge,MRC Cancer Unit, Hutchison/MRC Research Centre
[7] Addenbrooke’s Hospital,Academic Laboratory of Medical Genetics, Lv 6 Addenbrooke’s Treatment Centre
[8] IEO,Unit of Gynecological Oncology Research
[9] European Institute of Oncology IRCCS,undefined
来源：
BRITISH JOURNAL OF CANCER | 2023年 / 128卷 / 07期
关键词：
D O I：
10.1038/s41416-023-02205-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1405 / 1405
页数：1
相关论文
共 8 条
  • [1] Basal expression of RAD51 foci predicts olaparib response in patient-derived ovarian cancer xenografts
    Guffanti, F.
    Alvisi, M. F.
    Anastasia, A.
    Ricci, F.
    Chiappa, M.
    Llop-Guevara, A.
    Serra, V
    Fruscio, R.
    Degasperi, A.
    Nik-Zainal, S.
    Bani, M. R.
    Lupia, M.
    Giavazzi, R.
    Rulli, E.
    Damia, G.
    BRITISH JOURNAL OF CANCER, 2022, 126 (01) : 120 - 128
  • [2] Basal expression of RAD51 foci predicts olaparib response in patient-derived ovarian cancer xenografts
    F. Guffanti
    M F Alvisi
    A. Anastasia
    F. Ricci
    M. Chiappa
    A. Llop-Guevara
    V. Serra
    R. Fruscio
    A. Degasperi
    S. Nik-Zainal
    M R Bani
    M. Lupia
    R. Giavazzi
    E. Rulli
    G. Damia
    British Journal of Cancer, 2022, 126 : 120 - 128
  • [3] Correction to: Basal expression of RAD51 foci predicts olaparib response in patient-derived ovarian cancer xenografts
    F. Guffanti
    M F Alvisi
    A. Anastasia
    F. Ricci
    M. Chiappa
    A. Llop-Guevara
    V. Serra
    R. Fruscio
    A. Degasperi
    S. Nik-Zainal
    M R Bani
    M. Lupia
    R. Giavazzi
    E. Rulli
    G. Damia
    British Journal of Cancer, 2023, 128 : 1405 - 1405
  • [4] RAD51 foci in patient-derived ovarian cancer organoids are associated with response to carboplatin and olaparib
    Compadre, Amanda
    van Biljon, Lillian
    Fashemi, Bisiayo
    Graham, Olivia
    Rodriguez, Jeimmy
    Lomonosova, Elena
    Blachut, Barbara
    Kuroki, Lindsay
    McCourt, Carolyn
    Hagemann, Andrea
    Thaker, Premal
    Massad, L.
    Powell, Matthew
    Mutch, David
    Fuh, Katherine
    Khabele, Dineo
    Mullen, Mary
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S308 - S309
  • [5] RAD51 recruitment but not replication fork stability associates with PARP inhibitor response in ovarian cancer patient-derived xenograft models
    Talens, Francien
    Teixeira, Vivian Oliviera Nunes
    Kok, Yannick P.
    Chen, Mengting
    Rosenberg, Efraim H.
    Debipersad, Rashmie
    Duiker, Evelien W.
    van den Tempel, Nathalie
    Janatova, Marketa
    Zemankova, Petra
    Nederlof, Petra M.
    Wisman, G. Bea A.
    Kleibl, Zdenek
    de Jong, Steven
    van Vugt, Marcel A. T. M.
    NAR CANCER, 2024, 6 (04):
  • [6] An ex vivo assay of XRT-induced Rad51 foci formation predicts response to PARP-inhibition in ovarian cancer
    Shah, Monjri M.
    Dobbin, Zachary C.
    Nowsheen, Somaira
    Wielgos, Monica
    Katre, Ashwini A.
    Alvarez, Ronald D.
    Konstantinopoulos, Panagiotis A.
    Yang, Eddy S.
    Landen, Charles N.
    GYNECOLOGIC ONCOLOGY, 2014, 134 (02) : 331 - 337
  • [7] BRCA1 foci test as a predictive biomarker of olaparib response in ovarian cancer patient-derived xenograft models
    Guffanti, Federica
    Mengoli, Ilaria
    Alvisi, Maria Francesca
    Dellavedova, Giulia
    Giavazzi, Raffaella
    Fruscio, Robert
    Rulli, Eliana
    Damia, Giovanna
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [8] Impact of ERCC1, XPF and DNA Polymerase β Expression on Platinum Response in Patient-Derived Ovarian Cancer Xenografts
    Guffanti, Federica
    Alvisi, Maria Francesca
    Caiola, Elisa
    Ricci, Francesca
    De Maglie, Marcella
    Soldati, Sabina
    Ganzinelli, Monica
    Decio, Alessandra
    Giavazzi, Raffaella
    Rulli, Eliana
    Damia, Giovanna
    CANCERS, 2020, 12 (09) : 1 - 14
1